Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5K0K

Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC2434

5K0K の概要
エントリーDOI10.2210/pdb5k0k/pdb
関連するPDBエントリー5K0X
分子名称Tyrosine-protein kinase Mer, CHLORIDE ION, 15-{4-[(4-methylpiperazin-1-yl)methyl]phenyl}-4,5,6,7,9,10,11,12-octahydro-2,16-(azenometheno)pyrrolo[2,1-d][1,3,5,9]te traazacyclotetradecin-8(3H)-one, ... (5 entities in total)
機能のキーワードmacrocyclic, pyrrolopyrimidines, drug design, fibrinolytic agents, protein kinase inhibitors, proto-oncogene proteins, pyrimidines, receptor protein-tyrosine kinases, structure-activity relationship, thrombosis, transferase-transferase inhibitor complex, transferase/transferase inhibitor
由来する生物種Homo sapiens (Human)
細胞内の位置Membrane ; Single-pass type I membrane protein : Q12866
タンパク質・核酸の鎖数2
化学式量合計72939.09
構造登録者
主引用文献Wang, X.,Liu, J.,Zhang, W.,Stashko, M.A.,Nichols, J.,Miley, M.J.,Norris-Drouin, J.,Chen, Z.,Machius, M.,DeRyckere, D.,Wood, E.,Graham, D.K.,Earp, H.S.,Kireev, D.,Frye, S.V.
Design and Synthesis of Novel Macrocyclic Mer Tyrosine Kinase Inhibitors.
ACS Med Chem Lett, 7:1044-1049, 2016
Cited by
PubMed: 27994735
DOI: 10.1021/acsmedchemlett.6b00221
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.545 Å)
構造検証レポート
Validation report summary of 5k0k
検証レポート(詳細版)ダウンロードをダウンロード

218853

件を2024-04-24に公開中

PDB statisticsPDBj update infoContact PDBjnumon